Cellular Therapy With Human Autologous Adipose-Derived Adult Stem Cells for Advanced Keratoconus
Conclusions: Cellular therapy of the human corneal stroma in vivo with autologous ADASCs appears to be safe. Stem cells survive in vivo with intrastromal new collagen production. Future studies with larger samples are required to confirm these preliminary results.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
More News: Anesthesia | Anesthesiology | Liposuction | Science | Stem Cell Therapy | Stem Cells | Study